Previous Article | Next Article ![]()
Applied and Environmental Microbiology, October 2008, p. 6254-6262, Vol. 74, No. 20
0099-2240/08/$08.00+0 doi:10.1128/AEM.00109-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
,
Institute of Oceanology, Chinese Academy of Sciences, Qingdao 266071, People's Republic of China,1 Graduate University of the Chinese Academy of Sciences, Beijing 100049, People's Republic of China2
Received 14 January 2008/ Accepted 13 August 2008
|
|
|---|
E-like factor. Enzymatic analyses demonstrated that the recombinant DegQVh protein expressed in and purified from E. coli was an active serine protease whose activity required the integrity of the catalytic site and the PDZ domains. The optimal temperature and pH of the recombinant DegQVh protein were 50°C and pH 8.0. A vaccination study indicated that the purified recombinant DegQVh was a protective immunogen that could confer protection upon fish against infection by V. harveyi. In order to improve the efficiency of DegQVh as a vaccine, a genetic construct in the form of the plasmid pAQ1 was built, in which the DNA encoding the processed DegQVh protein was fused with the DNA encoding the secretion region of AgaV, an extracellular β-agarase. The E. coli strain harboring pAQ1 could express and secrete the chimeric DegQVh protein into the culture supernatant. Vaccination of fish with viable E. coli expressing chimeric degQVh significantly (P < 0.001) enhanced the survival of fish against V. harveyi challenge, which was possibly due to the relatively prolonged exposure of the immune system to the recombinant antigen produced constitutively, albeit at a gradually decreasing level, by the carrier strain. |
|
|---|
36% identical to DegP, whose coding sequence is physically separated from the degQ-degS cluster. DegP is involved in the refolding/degradation of abnormal proteins accumulated in the periplasm; degP mutation vitiates bacterial virulence (9, 13-15, 29, 45) and impairs growth under certain stringent conditions, notably those caused by heat shock (23, 30, 35, 40, 46). Mutation of degQ does not lead to any observable growth defect in E. coli but affects the survival of Salmonella enterica serovar Typhimurium in the host (8). Inactivation of degS attenuates virulence in a number of bacterial species, probably on account of the fact that DegS regulates the activity of
E, the alternate sigma factor that controls the expression of genes, such as degP, that are essential to the viability of cells under stress conditions (1, 10, 48). Vibrio harveyi is a gram-negative bacterium of the family Vibrionaceae and one of the important pathogens of cultured marine animals. Owing to its broad host range, which includes peneid shrimp, sea cucumber, and fish of various species (31), V. harveyi has caused severe losses to aquiculture industries worldwide. Recently genome sequencing data have revealed the ubiquitous existence of HtrA homologues in the Vibrio species, yet no characterization of these proteins has been documented. By utilizing a secretion signal trap developed in our laboratory (49), we cloned the genetic cluster containing the degQ and degS paralogues from a virulent V. harveyi strain. Our aim was to investigate whether there was any difference in functional and biochemical aspects between V. harveyi DegQ (DegQVh) and other known DegQ proteins and whether DegQVh could be explored in some new directions that would lead to its application in disease control. Our results indicated that DegQVh was an endoprotease and a vaccine candidate against V. harveyi infection.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Bacterial strains and plasmids used in this study
|
Chemicals.
All chemicals used in this study were purchased from Sangon (China) except for azocasein (Sigma-Aldrich) and collagen (Worthington).
Plasmid and strain constructions.
The plasmids used in this study are listed in Table 1. The primers used in this study are listed in Table S1 in the supplemental material. To construct pBRL, Plac of pEGFP (Clontech) (amplified by PCR with the primers LacPF1/LacPR1) was inserted into pBR322 between the EcoRI and BamHI sites. pBVQ1 and pBVQ2 were generated by ligating the wild-type and mutant degQVh genes (amplified by PCR with the primer pairs VQF15/VQR5 and VQF15/VQR19, respectively) into pBRL at the BamHI site. pBEP and pBEQ were constructed by inserting the E. coli degP and degQ genes (amplified by PCR with the primer pairs EPF3/EPR3 and EQF3/EQR3, respectively) into pBRL at the BamHI site. pETQ was constructed by ligating degQVh (amplified by PCR with the primers VQF25/VQR2) into pET258 between the NdeI/XhoI sites. To construct pBT3, the rrnB transcription terminator of pTrcHis (Invitrogen) (amplified by PCR with the primers RNBF1/RNBR1) was ligated to the 2.8-kb EcoRV/BsaBI fragment of pBR322, yielding pBRB, which was then cut with EcoRI/BamHI and ligated to the Ptrc promoter of pTrcHis, resulting in pBT; the NdeI site of pBT was inactivated by filling in with a 36-bp oligonucleotide (5'-TACAATAGTATAGTGGTAGCTTGTAGATCTAGATAG-3'), and the resulting plasmid was digested with BamHI and ligated to a His-tagged NdeI-XhoI linker (5'-GATCCAAGGAGATATACATATGGATATCCTCGAGCACCACCACCACCACCACTAAG-3'), yielding pBT3. pBQ was constructed by inserting degQVh of pETQ into the NdeI/XhoI sites of pBT3. To construct pBTA1 and pBTA2, the DNA encoding the N-terminal 107- and 195-amino-acid residues of AgaV (amplified by PCR with the primer pairs UAF7/UAR9 and UAF7/UAR11, respectively) was inserted into pBT3 at the BamHI site. pAQ1 and pAQ2 were generated by inserting degQVh (amplified by PCR with the primers VQF3/VQR2) into the NdeI/XhoI sites of pBTA1 and pBTA2, respectively. To construct pEF and pMBP, lacO-less Plac (generated by PCR with primers LacpF1/LacPR4) of pEGFP was inserted into pBRB between the EcoRI-BamHI sites, yielding pLS; the above-described His-tagged NdeI-XhoI linker was then inserted into pLS at the BamHI site, resulting in pL2; the E. coli ferric uptake regulator gene (fur; generated by PCR with primers EFF7/EFR11) and the maltose binding protein gene (malE; generated by PCR with primers MalF1/MalR1) were inserted into pL2 between the NdeI-XhoI sites, resulting in pLE and pLM, respectively, which were digested with SwaI, and the fragments containing Plac-fur and Plac-malE were ligated to pACYC184 linearized with EcoRV, resulting in pEF and pMBP, respectively.
For the construction of the E. coli strain EMZ1, the cat gene of pACYC184 was inserted into pGP704 between the PstI and SalI sites, resulting in p704C, which was linearized with EcoRV and ligated to an internal fragment of E. coli degP (amplified by PCR with the primers DegPF1/DegPR1), resulting in pGPD, which was introduced into S17-1
pir by transformation; the transformants were mated with N7K, an NK7047 variant that was resistant to kanamycin. The transconjugants were selected for chloramphenicol and kanamycin resistance on LB agar plates. One of the selected clones was named EMZ1, which was confirmed to have degP inactivated by PCR and growth analysis, the latter showing that EMZ1 could grow at 37°C but not at 42°C and its growth defect could be rescued by DegP (Fig. 1).
![]() View larger version (32K): [in a new window] |
FIG. 1. Effect of DegQVh and the E. coli DegP and DegQ proteins on the growth of EMZ1 at high temperature. N7K and EMZ1 harboring pBRL derivatives were grown at 42°C in the absence or presence of different concentrations of IPTG; aliquots were taken at different time points for the measurement of absorbance at OD600. Data are the means for at least three independent experiments and are presented as the means ± SE.
|
pETQD2 and pETQD12 were created by ligating the PCR products generated with the primer pairs VQF25/VQR14 and VQF25/VQR13, respectively, into pET258 between the NdeI/XhoI sites.
Cloning of the degQVh cluster.
T4 genomic DNA was digested with Sau3A1, and the fragments between 4 and 6 kb were recovered and ligated into pBU at the BamHI site; DH5
was transformed with the ligation mix, and the transformants were selected as described previously (49). The complete sequence of the degQVh cluster was obtained by genome walking as described previously (49).
Expression and purification of wild-type and mutant recombinant DegQVh.
BL21(DE3) was transformed with pET258 carrying degQVh variants; the transformants were grown in LB medium to an optical density at 600 nm (OD600) of 0.7, and the expression of the recombinant proteins was induced by adding to the culture 1 µM isopropyl-β-D-thiogalactopyranoside (IPTG). After an additional 5 h of growth, the cells were harvested and the recombinant proteins were purified with nickel-nitrilotriacetic acid agarose as described previously (49).
Purification of recombinant E. coli Fur.
The coding sequence of the E. coli fur gene (amplified by PCR with primers EFF7/EFR11) was inserted into pET258 between the NdeI-XhoI sites, resulting in pETEF. BL21(DE3) was transformed with pETEF, and the recombinant Fur was purified from BL21(DE3)/pETEF by using nickel-nitrilotriacetic acid beads.
Real-time RT-PCR.
Total RNA was extracted from cells grown in LB medium to various densities by using the SV total RNA isolation system (Promega). Real-time reverse transcriptase PCR (RT-PCR) was carried out in an ABI 7300 real-time detection system (Applied Biosystems) by using the Sybr ExScript RT-PCR kit (Takara, China). The primers used for RT-PCR of degQVh were DF14 (5'-CACCCCAGTCACCGCAA-3') and DR14 (5'-GACGCTCACGAGTTTGTTCTGT-3'). Each assay was performed in triplicate with the 16S rRNA as a control. The primers used for the RT-PCR of 16S rRNA were 933F (5'-GCACAAGCGGTGGAGCATGTGG-3') and 16SRTR1 (5'-CGTGTGTAGCCCTGGTCGTA-3'). The amplification efficiencies of the control and the sample were 99.99 and 100%, respectively. Dissociation analysis of amplification products was performed at the end of each PCR to confirm that only one PCR product was amplified and detected. The comparative threshold cycle method (2–
CT method) was used to analyze the mRNA level. All data were given in terms of relative mRNA, expressed as means plus or minus standard errors of the means (SE). Statistical analyses were performed by using the two-tailed Student t test.
Enzyme assay.
The protease activity of purified recombinant DegQVh was analyzed by incubating the protein, which had been diluted to various concentrations, with β-casein (0.5 mg/ml) in the standard assay buffer (50 mM potassium phosphate [pH 7.4]) at 37°C for 1 h. The samples were then boiled for 2 min and electrophoresed in a 0.1% sodium dodecyl sulfate (SDS)-12% polyacrylamide gel. The effect of pH on the enzyme activity was determined by incubating the enzyme with azocasein (0.5%) at 50°C for 1 h in three different buffers: 50 mM citric acid-sodium phosphate (pH 4 to 6), 50 mM sodium phosphate (pH 6 to 9), and 50 mM glycine-NaOH (pH 9 to 11); the reaction was stopped by the addition of an equal volume of 10% trichloroacetic acid followed by incubation at 4°C for 15 min; the sample was then centrifuged, and the supernatant was used for the measurement of absorbance at 350 nm. The effect of temperature on the activity of DegQVh was assayed as described above for the effect of pH except that the reaction was performed in the standard assay buffer at various temperature points.
Western and immunoblot analysis.
Cells were grown in LB medium to an OD600 of
1.2 and harvested by centrifugation at 4°C. The extracellular proteins were prepared by concentrating the supernatant
100 times using Amicon Ultra-4 centrifugal filter devices (Millipore); the whole-cell proteins were prepared by lysing the cell pellet in the lysis buffer (100 mM NaH2PO4, 10 mM Tris-Cl, and 8 M urea; pH 8.0), followed by centrifugation at 4°C to remove the debris; the periplasmic proteins were prepared according to the method of Flannagan et al. (9). The proteins obtained were electrophoresed in 0.1% SDS-12% polyacrylamide gels. After electrophoresis, the proteins were transferred to nitrocellulose membranes. Immunoblotting was performed as described previously (24) using mouse anti-His monoclonal antibody (Tiangen, China) and anti-Fur and anti-DegQVh polyclonal antibodies.
Antisera.
Antisera to recombinant DegQVh and Fur were prepared by subcutaneously injecting adult rabbits (purchased from the Institute for Drug Control, Qingdao, China) with 200 µg of purified recombinant protein mixed in complete Freund's adjuvant, followed by a boost with the same amount of protein in incomplete Freund's adjuvant 3 weeks later. The rabbits were bled 12 days after the boosting, and the blood was collected, from which the sera were obtained by centrifugation and used for Western immunoblotting and enzyme-linked immunosorbent assay, which was performed according to the method of Kawai et al. (16).
Northern dot blotting.
Sixteen micrograms of RNA was spotted onto a Hybond-N+ nitrocellulose membrane (Amersham Biosciences), and hybridization was carried out at 42°C according to the protocol recommended by Amersham Biosciences using biotin-labeled DNA probes. The labeling of the probe was carried out by using the Randon Primer DNA labeling kit (Beyotime, China). After hybridization, the hybridized RNA was detected by using a chemiluminescent biotin-labeled nucleic acid detection kit (Beyotime, China). Densitometry was performed by using the SensiAnsys gel analysis system (Peiqing, China).
Fish vaccination and challenge.
Healthy Japanese flounder (average weight, 11 g) were purchased from a commercial fish farm in China. The fish were reared at 20 to 22°C in seawater and fed daily with commercial dry pellets. For the vaccination experiment, strain B187 was grown in LB medium to an OD600 of 0.6; the cells were harvested and washed in phosphate-buffered saline (PBS). Washed B187 was resuspended in PBS to 2 x 108 CFU/ml (calculated based on the result of a viable count which showed that at an OD600 of 0.6, 1 ml of BB187 contained
4.8 x 108 viable cells). Purified recombinant DegQVh was mixed into the above B187-PBS solution to a concentration of 250 µg/ml. Eighty-four Japanese flounder were divided randomly into two groups (42 fish/group), designated A and B. Fish in group A were each injected intraperitoneally (i.p.) with 100 µl of B187-PBS-DegQVh mix, whereas fish in group B were each injected i.p. with 100 µl of B187-PBS. To reduce the stress associated with injection, the fish were stunned by being immersed in ice-seawater immediately before the injection. Three weeks postimmunization, the fish of group A were boosted with 20 µg of purified DegQVh diluted in PBS without B187 while the fish in group B were sham boosted with PBS. At the 13th day postboosting, the fish were challenged with strain T4, which had been cultured in LB medium, washed, and resuspended in PBS. Mortality was monitored over a period of 14 days after the challenge, and the relative percentage of survival (RPS) was calculated according to the following formula: RPS = [1 – (% mortality in vaccinated fish/% mortality in control fish)] x 100 (2). Vaccinations with DegQVh against HH2 and TX1 challenges were carried out in the same fashion.
For vaccination with live recombinant DH5
, two groups (42 fish/group) of flounder were i.p. injected with either 100 µl of live recombinant DH5
that had been grown in LB medium to late logarithmic phase, washed, and resuspended in PBS to 2 x 108 CFU/ml or, for the control group, 100 µl of PBS. The fish were challenged as described above, and mortality was monitored for 14 days postchallenge. The RPS was calculated as described above.
All vaccination experiments were repeated once. Statistical analysis was performed by using the chi-square test with Yates' correction.
Bacterial survival in vaccinated fish.
Japanese flounder were immunized via i.p. injection with DH5
carrying pAQ1, pBQ, and pBTA1; at least three fish were sacrificed at 2, 3, 4, 7, 10, and 13 days postimmunization, and the peritoneal fluids, guts, spleen, and liver were removed aseptically. The peritoneal fluids were diluted in PBS and plated on LB agar plates supplemented with ampicillin (marker for pAQ1, pBQ, and pBTA1); the organs were homogenized with glass homogenizers before being plated on LB plates containing ampicillin. The plates were incubated at 37°C for 24 h; the colonies that emerged were examined by PCR using the plasmid- and E. coli-specific primers and subsequent sequencing of the PCR products.
Database search.
The database search was conducted using the BLAST programs at the NCBI. The signal peptide search and predictions were performed using the SignalP 3.0 server.
Nucleotide sequence accession number.
The nucleotide sequence of the degQVh (under the name vhdQ) cluster has been deposited in the GenBank database under the accession number EU344975.
|
|
|---|
DegQVh could complement the mutant phenotype of an E. coli strain defective in degP.
In E. coli, degP mutation is known to affect bacterial growth at elevated temperatures. Since we failed to generate a T4 isogenic strain with a mutated degQVh locus after several attempts, we were unable to study the function of DegQVh with the native genetic background. We therefore adopted the complementation approach, through which the effect of degQVh on an E. coli degP mutant, EMZ1, was analyzed. For this purpose, the plasmids pBVQ1, pBVQ2, pBEQ, and pBEP were constructed, in which wild-type degQVh, a degQVh mutant bearing a deletion of the PDZ domains, the E. coli degQ gene, and the E. coli degP gene are expressed under the lactose promoter Plac and thus are inducible by IPTG. The E. coli strain EMZ1, which was unable to grow at 42°C as a result of degP inactivation, was transformed with pBVQ1, pBVQ2, pBEQ, pBEP, and the control plasmid pBRL; the transformants were examined for growth at 42°C in the presence or absence of IPTG. The result showed that EMZ1 harboring pBVQ1 was able to grow at the temperature that was otherwise lethal to the host strain (Fig. 1); furthermore, the growth of EMZ1/pBVQ1 at 42°C was a function of the induction level of degQVh and dependent on the protease activity of DegQVh, since pBVQ2, which carries a proteolytically defective degQVh mutant, failed to rescue EMZ1 grown at 42°C. Under the condition of full induction (i.e., in the presence of 100 µM IPTG), EMZ1/pBVQ1 grown at 42°C exhibited a slower doubling time and a lower maximum cell density than EMZ1/pBEQ and more so than EMZ1/pBEP (Fig. 1), suggesting that the complementation ability of DegQVh was less than that of E. coli DegQ and less than that of E. coli DegP. Amino acid sequence comparison revealed that DegQVh is 57 and 56% identical to E. coli DegP and DegQ, respectively, and most of the identities are clustered at the protease domain, especially around the catalytic site.
Expression of degQVh was modulated by temperature.
It is known that expression of the E. coli degP gene is regulated by temperature (44); to investigate whether temperature had any effect on the expression of degQVh, T4 was grown in LB medium at 28°C to an OD600 of 0.2; the cells were then divided into two parts; the first part was cultured continuously at 28°C, while the second part was cultured at 37°C (sublethal temperature) for 5, 10, and 30 min. Total RNA was extracted from cells harvested at different growth points and used for real-time RT-PCR analysis of degQVh expression and for Northern blotting analysis of 16S rRNA transcription. The result of Northern dot blotting showed that the differences in the transcription level of 16S rRNA were between 1- and 1.4-fold among the cells grown to an OD600 of 0.2 to 0.8 at 28°C and at 37°C (data not shown), suggesting that for T4 the above-specified temperatures and growth phase had only minor effects on the transcription of 16S rRNA. Hence, 16S rRNA was used as an internal control in the real-time RT-PCR analysis of degQVh. The result showed that shifting of the temperature from 28°C to 37°C caused an immediate 10.3-fold increase in the expression of degQVh (Fig. 2); however, the enhancement effect of high temperature appeared to be transient, since prolonged (10 and 30 min) incubation at 37°C drastically reduced degQVh expression (Fig. 2). Inspection of the sequence between orf444 and degQVh revealed a potential rho-independent transcription terminator, followed by a putative promoter (named PdegQ) (Fig. 3) with sequence modules resembling those of the E. coli
E,
32, and degP promoters, which are known to be
E dependent and inducible by heat shock (7, 22, 32). The putative –35 (GAACTT) and –10 (TCTAA) elements of PdegQ are perfect matches to those of the P2 promoter of E. coli
E, though the space between the –35 and –10 elements is 1 bp longer in PdegQ. These results suggested the possibility that in T4, expression of degQVh was regulated by a
E-like factor under conditions of elevated temperature.
![]() View larger version (17K): [in a new window] |
FIG. 2. Expression of degQVh was modulated by temperature. T4 was grown in LB medium at 28°C to an OD600 of 0.2; half of the cell culture was removed and grown separately at 37°C for 5, 10, and 30 min while the remaining half of the cell culture was grown continuously at 28°C. Total RNA was extracted from cells grown at 28°C (black bar) or 37°C (white bar) at different growth points and used for real-time RT-PCR. The degQVh mRNA level was normalized to that of 16S rRNA. Data are the means for three independent experiments and are presented as the means ± SE. *, P < 0.001.
|
![]() View larger version (30K): [in a new window] |
FIG. 3. Nucleotide sequence of the intergenic region between orf444 and degQVh. The translation stop and start codons of orf444 and degQVh, respectively, are in bold capital letters; the putative rho-independent transcription terminator is in italics; the putative –35 and –10 elements of PdegQ are in bold and underlined.
|
![]() View larger version (63K): [in a new window] |
FIG. 4. Enzymatic analysis of purified recombinant DegQVh. The assay was performed at 37°C in the standard assay buffer containing various concentrations of purified recombinant DegQVh and β-casein with or without PMSF (10 mM). After 1 h of reaction, the samples were boiled for 2 min and electrophoresed in a 0.1% SDS-12% polyacrylamide gel. After electrophoresis the gel was stained with Coomassie blue.
|
|
View this table: [in a new window] |
TABLE 2. Effects of mutation of the catalytic site and deletion of the PDZ domains on protease activity of purified recombinant DegQVh
|
![]() View larger version (17K): [in a new window] |
FIG. 5. Effect of pH (A) or temperature (B) on the activity of purified recombinant DegQVh. (A) The effect of pH was determined in three different buffers using azocasein (0.5%) as a substrate: 50 mM citric acid-sodium phosphate (pH 4 to 6; ), 50 mM sodium phosphate (pH 6 to 9; ), and 50 mM glycine-NaOH (pH 9 to 11; ). (B) The effect of temperature ( ) was determined in the standard assay buffer at temperatures between 10 and 70°C with azocasein (0.5%) as a substrate. Thermostability ( ) was determined by preincubating the enzyme in the standard assay buffer at the indicated temperature for 1 h before initiating the enzymatic reaction by the addition of azocasein (0.5%). Data are the means for at least three independent experiments and are presented as means ± SE.
|
|
View this table: [in a new window] |
TABLE 3. Effects of cations and EDTA on activity of purified recombinant DegQVh
|
Construction and delivery of a secreted form of DegQVh as a more effective vaccine candidate.
Western immunoblotting analysis showed that in DH5
the recombinant DegQVh protein, guided by its native secretion signal, was localized in the periplasmic space (Fig. 6). To facilitate the application and improve the efficiency of DegQVh as a vaccine, we wanted to engineer a genetic system that could express and deliver DegQVh as a secreted immunogen. For this purpose, we built several translational fusions consisting of the mature DegQVh protein preceded by different secretion segments of AgaV, an extracellular β-agarase described previously (49). The fusions were inserted into the expression plasmid pBT3 and expressed constitutively under the Ptrc promoter. DH5
harboring one of the constructs, pAQ1, in which the mature DegQVh protein was fused to the N-terminal (1 to 107) region of AgaV (AgaV107), was able to secret the chimeric AgaV107-DegQVh protein into the culture supernatant (Fig. 6), whereas DH5
harboring pAQ2, in which the mature DegQVh protein was fused to the N-terminal (1 to 195) region of AgaV (AgaV195), retained the chimeric AgaV195-DegQVh protein in the periplasm. To examine whether the detected proteins in the supernatant and periplasm were due to contaminations of cytoplasmic/periplasmic proteins, the plasmids pEF and pMBP were introduced separately into DH5
/pAQ1 and DH5
/pAQ2. pEF constitutively expresses the E. coli ferric uptake regulator (Fur), a cytoplasmic protein, and pMBP constitutively expresses a His-tagged E. coli periplasmic maltose binding protein (MalE). The transformants DH5
/pAQ1/pEF, DH5
/pAQ2/pEF, DH5
/pAQ1/pMBP, and DH5
/pAQ2/pMBP were cultured to an OD600 of 0.9 in LB medium; proteins in the periplasm and the supernatant of the cultures were prepared and subjected to Western immunoblotting using antibodies against DegQVh, Fur, and the histidine tag. The result showed that immunoblotting using anti-Fur antibodies produced no positive result; immunoblotting using anti-His antibodies detected MalE only in the periplasmic preparations of DH5
/pAQ1/pMBP and DH5
/pAQ2/pMBP; immunoblotting using anti-DegQVh antibodies detected DegQVh in the periplasmic preparations of all the cultures but only in the supernatants of DH5
/pAQ1/pEF and DH5
/pAQ1/pMBP (data not shown). These results demonstrated that while DH5
harboring pAQ2 could produce and transport the chimeric DegQVh protein into the periplasm, DH5
harboring pAQ1 could secret the chimeric DegQVh protein into the culturing supernatant. Vaccination study showed that compared to vaccination with the purified DegQVh (RPS of 64.9%), vaccination with live DH5
/pAQ1 significantly (P < 0.001) increased the survival rate of fish against T4 (RPS of 94.6%), whereas vaccination with live DH5
harboring pBQ (the plasmid that expresses degQVh) resulted in an RPS of 86.5%. In contrast, immunization with live DH5
harboring pBTA1 (the control vector) had no apparent effect (RPS of <15%), although mortality started 1 day later than that in fish immunized with PBS. Therefore, as a protective immunogen, DegQVh delivered by live DH5
in the secreted chimeric form appeared to be more effective than DegQVh in the periplasm-localized form, and both were more effective than DegQVh administered in the form of purified recombinant protein.
![]() View larger version (18K): [in a new window] |
FIG. 6. Subcellular localization of the wild type and chimeric DegQVh in DH5 . Cells were grown in LB medium to an OD600 of 1.2 and used for the preparation of the periplasmic, extracellular, and whole-cell proteins. The proteins were electrophoresed in a 0.1% SDS-12% polyacrylamide gel. For proteins from the same cellular compartment, equal volumes were loaded into the gel. After electrophoresis, the proteins were transferred to a nitrocellulose membrane and immunoblotted with mouse anti-His monoclonal antibody.
|
/pAQ1 and DH5
/pBQ was the result of prolonged existence of the immunogen, the in vivo survival of the carrier strain was investigated. To this end the peritoneal fluids, guts, spleen, and liver of the fish immunized with DH5
/pAQ1, DH5
/pBQ, and DH5
/pBTA1 were examined at various time points postvaccination for viable plasmid-harboring DH5
. The result showed that plasmid-retaining DH5
cells could be recovered from the peritoneal fluids but not from the guts, spleen, or liver of the immunized fish as late as 7 days postimmunization, with the number of viable cells being highest at the early days and declining with time (Fig. 7). This result suggested that there was a prolonged, though relatively short, duration of the presence of low-level DegQVh-producing DH5
cells in the vaccinated fish, which may have contributed to the enhanced protective effect observed with DH5
/pAQ1 and DH5
/pBQ.
![]() View larger version (28K): [in a new window] |
FIG. 7. Survival of antigen carrier strains in vaccinated fish. The peritoneal fluids of the fish immunized with DH5 carrying pBQ, pAQ1, and pBTA1 were taken at different days postvaccination and examined for viable plasmid-retaining E. coli cells. The data are means for at least three independent assays and are presented as the means ± SE.
|
|
|
|---|
Studies of E. coli DegP and DegQ reveal that they exhibit very similar substrate specificities and degrade proteins that are transiently or irreversibly denatured (20). The known substrates for DegP include β-casein (43), MalS (38), PhoA (37), maltose binding protein (4), OmpF (26), and PapA pilin (15), which are naturally or unnaturally misfolded. The protease activity of E. coli DegP manifests only when the temperature is above 20°C and increases rapidly between 37 and 55°C (36, 39). In our study we found that DegQVh could degrade the loosely structured β-casein but not the well-structured BSA or collagen. Like the E. coli DegP protein, DegQVh was proteolytically active over a wide pH range and in the presence of different cations. In line with the observation that it could rescue the temperature-sensitive defect of an E. coli DegP mutant, recombinant DegQVh was most active over the temperature range of 40 to 50°C and was thermostable. As has been observed with the HtrA protein of E. coli, Burkholderia cepacia, and T. maritime (9, 18, 34), the proteolytic activity of DegQVh required the presence of both PDZ1 and PDZ2. The PDZ domains of E. coli DegP have been proposed to be involved in vital enzymatic processes, including temperature-dependent substrate binding and translocation of the bound substrate to the catalytic cavity (5, 34). Recent studies by Kim and Kim (18) demonstrated that PDZ2 of T. maritime HtrA, the only DegQ homologue with the protease domain analyzed at the crystal structure level (17, 18), functions in the formation of the oligomeric protein complex (19). The essentialness of the PDZ domains of DegQVh suggested that they may play a role analogous to that played by the PDZ domains of the E. coli and T. maritime HtrA proteins.
E. coli serving as an expression and delivery vehicle for exogenous antigens has been reported previously by Onate et al. (27) and Andrews et al. (3), who showed that vaccination of mice with live E. coli producing the Cu/Zn superoxide dismutase of Brucella abortus can elicit a strong protective immune response. Similarly, we found that immunization of fish with viable E. coli expressing degQVh induced effective protection. The greater protective effect of the chimeric over the periplasmic DegQVh protein was probably due to the soluble nature of the former, which may increase the accessibility of DegQVh by host immune systems; the carrier protein, AgaV, may also contribute to the protection by playing a structural role, so that DegQVh in the chimeric form was more effectively presented as an immunogen. The inability of DH5
carrying the control vector to induce any protection ruled out the possibility that the protection observed with DH5
/pAQ1 and DH5
/pBQ was due to nonspecific immune responses elicited by the carrier strain, DH5
, or expression of the backbone plasmid components; rather, it suggested that the protection was mediated specifically by DegQVh in its respective form. However, the immune responses elicited by the carrier strain, DH5
, may have facilitated the induction or boosted the scale of the DegQVh-specific immune response, which could in part account for the observation that DegQVh presented by live DH5
cells was a more potent immunogen than DegQVh in the form of a purified subunit vaccine. The nature of the immune responses induced by the purified recombinant DegQVh protein and by DH5
/pAQ1 is currently under study in our laboratory. It is a possibility that compared to vaccination with purified DegQVh, vaccination with a genetically altered form of DegQVh presented by live E. coli cells may lead to alterations in certain aspects of the host immune responses.
Published ahead of print on 22 August 2008. ![]()
Supplemental material for this article may be found at http://aem.asm.org/. ![]()
|
|
|---|
-producing cell. Microbiol. Immunol. 50:389-393.[Medline]This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»